Replay available

Evonik Industries Ag (EVKIF) Q2 2025 Earnings Call

Evonik Industries Ag (OTC: EVKIF) Q2 2025 earnings conference call, held 2025-08-01. Replay captured from the company's public earnings webcast.

Fri, August 1, 2025 at 5:00 AMendedReplay
Evonik Industries Ag (EVKIF) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Christian Kuhlmann

CEO

Georgina Fraser

Analyst, Goldman Sachs

David Simmons

Analyst, BNP Paribas

Thomas Rigglesworth

Analyst, Morgan Stanley

Chaitanu Deshi

Analyst, JPMorgan

Martin Rediger

Analyst, Kepler Cheuvreux

Matthew Yates

Analyst, Bank of America

Lano Fanil Shenoy

Analyst, Barclays

Unknown Speaker

Replay transcript excerpt

Ladies and gentlemen, welcome to the Evonik Industries AG Q2 2025 earnings conference call. I am Konstantinos, the course call operator. I would like to remind you that all participants will be in listening mode and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star then 0. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Christian Kuhlmann, CEO. Please go ahead. Thanks a lot and welcome to our Q2 earnings call, ladies and gentlemen. Last time we met in May. We had a quite solid April in our books and we're expecting similar months ahead of us. Today, we all know that the last month of the second quarter got pretty tough across most industries. Still, we could deliver a decent second quarter and to stick to our full year guidance. Admittingly, that's the low end of the range. Having said so, a no. Your main question for today will be, is it still a doable target? Let us give you a first answer by taking a simplified look at the first half of the year before then turning to the month ahead. Our Group MTA decline the first half of the year is more or less exclusively explained by two factors. First, the weakness in our C4 business and second, the US dollar exchange rate combined. they do stand for an EBITDA decline of more than €100 million. Farther further, this means a large part of our core chemicals portfolio could withstand the pressure in the first half of this year and showed quite some resilience. Our two chemical segments jointly even posted slighter higher earnings. Custom solutions remain stable thanks to our resilient editors' busines...

More from Evonik Industries Ag